Cargando…
Retraction note: Rituximab-conjugated, doxorubicin-loaded microbubbles as a theranostic modality in B-cell lymphoma
Autores principales: | Zhou, Shoubing, Zhang, Xiu, Wang, Cailian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352457/ https://www.ncbi.nlm.nih.gov/pubmed/28187534 http://dx.doi.org/10.18632/oncotarget.14897 |
Ejemplares similares
-
Rituximab-conjugated, doxorubicin-loaded microbubbles as a theranostic modality in B-cell lymphoma
por: Zhou, Shoubing, et al.
Publicado: (2016) -
Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells
por: Zhou, Shoubing, et al.
Publicado: (2017) -
Retracted: Preliminary Study on the Therapeutic Effect of Doxorubicin-Loaded Targeting Nanoparticles on Glioma
por: and Biomechanics, Applied Bionics
Publicado: (2023) -
Retracted: Study on the Application of Doxorubicin-Loaded Magnetic Nanodrugs in Targeted Therapy of Liver Cancer
por: and Biomechanics, Applied Bionics
Publicado: (2023) -
Microbubble–liposome conjugate: Payload evaluation of potential theranostic vehicle
por: Malik, Ritu, et al.
Publicado: (2016)